Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa.
COVID-19 vaccine
Diabetes
Hypertension
Metabolic syndrome
Obesity
Opportunistic screening
South Africa
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
20 11 2023
20 11 2023
Historique:
received:
14
09
2023
accepted:
08
11
2023
medline:
22
11
2023
pubmed:
21
11
2023
entrez:
21
11
2023
Statut:
epublish
Résumé
South Africa grapples with a substantial burden of non-communicable diseases (NCDs), particularly type 2 diabetes (diabetes) and hypertension. However, these conditions are often underdiagnosed and poorly managed, further exacerbated by the strained primary healthcare (PHC) system and the disruptive impact of the COVID-19 pandemic. Integrating NCD screening with large-scale healthcare initiatives, such as COVID-19 vaccination campaigns, offers a potential solution, especially in low- and middle-income countries (LMICs). We investigated the feasibility and effectiveness of this integration. A prospective cohort study was conducted at four government health facilities in Johannesburg, South Africa. NCD screening was incorporated into the COVID-19 vaccination campaign. Participants underwent COVID-19 rapid tests, blood glucose checks, blood pressure assessments, and anthropometric measurements. Those with elevated blood glucose or blood pressure values received referrals for diagnostic confirmation at local PHC centers. Among 1,376 participants screened, the overall diabetes prevalence was 4.1%, combining previously diagnosed cases and newly identified elevated blood glucose levels. Similarly, the hypertension prevalence was 19.4%, comprising pre-existing diagnoses and newly detected elevated blood pressure cases. Notably, 46.1% of participants displayed waist circumferences indicative of metabolic syndrome, more prevalent among females. Impressively, 7.8% of all participants screened were potentially newly diagnosed with diabetes or hypertension. Approximately 50% of individuals with elevated blood glucose or blood pressure successfully linked to follow-up care within four weeks. Our study underscores the value of utilizing even brief healthcare interactions as opportunities for screening additional health conditions, thereby aiding the identification of previously undiagnosed cases. Integrating NCD screenings into routine healthcare visits holds promise, especially in resource-constrained settings. Nonetheless, concerted efforts to strengthen care linkage are crucial for holistic NCD management and control. These findings provide actionable insights for addressing the NCD challenge and improving healthcare delivery in LMICs.
Sections du résumé
BACKGROUND
South Africa grapples with a substantial burden of non-communicable diseases (NCDs), particularly type 2 diabetes (diabetes) and hypertension. However, these conditions are often underdiagnosed and poorly managed, further exacerbated by the strained primary healthcare (PHC) system and the disruptive impact of the COVID-19 pandemic. Integrating NCD screening with large-scale healthcare initiatives, such as COVID-19 vaccination campaigns, offers a potential solution, especially in low- and middle-income countries (LMICs). We investigated the feasibility and effectiveness of this integration.
METHODS
A prospective cohort study was conducted at four government health facilities in Johannesburg, South Africa. NCD screening was incorporated into the COVID-19 vaccination campaign. Participants underwent COVID-19 rapid tests, blood glucose checks, blood pressure assessments, and anthropometric measurements. Those with elevated blood glucose or blood pressure values received referrals for diagnostic confirmation at local PHC centers.
RESULTS
Among 1,376 participants screened, the overall diabetes prevalence was 4.1%, combining previously diagnosed cases and newly identified elevated blood glucose levels. Similarly, the hypertension prevalence was 19.4%, comprising pre-existing diagnoses and newly detected elevated blood pressure cases. Notably, 46.1% of participants displayed waist circumferences indicative of metabolic syndrome, more prevalent among females. Impressively, 7.8% of all participants screened were potentially newly diagnosed with diabetes or hypertension. Approximately 50% of individuals with elevated blood glucose or blood pressure successfully linked to follow-up care within four weeks.
CONCLUSION
Our study underscores the value of utilizing even brief healthcare interactions as opportunities for screening additional health conditions, thereby aiding the identification of previously undiagnosed cases. Integrating NCD screenings into routine healthcare visits holds promise, especially in resource-constrained settings. Nonetheless, concerted efforts to strengthen care linkage are crucial for holistic NCD management and control. These findings provide actionable insights for addressing the NCD challenge and improving healthcare delivery in LMICs.
Identifiants
pubmed: 37986070
doi: 10.1186/s12889-023-17190-6
pii: 10.1186/s12889-023-17190-6
pmc: PMC10662646
doi:
Substances chimiques
COVID-19 Vaccines
0
Blood Glucose
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2291Subventions
Organisme : NIDDK NIH HHS
ID : K01 DK116929
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
BMC Public Health. 2017 Jan 11;17(1):61
pubmed: 28077105
BMC Public Health. 2014 Nov 18;14:1177
pubmed: 25407513
PLoS One. 2013 Nov 08;8(11):e78567
pubmed: 24250798
Postgrad Med J. 2001 May;77(907):323-5
pubmed: 11320276
SAGE Open Med. 2020 Nov 20;8:2050312120975235
pubmed: 33282310
PLoS One. 2016 Mar 01;11(3):e0150033
pubmed: 26930050
Health Res Policy Syst. 2011 Jan 28;9:5
pubmed: 21272381
Glob Health Action. 2018;11(1):1449924
pubmed: 29699475
Diabetes Res Clin Pract. 2014 Feb;103(2):197-205
pubmed: 24315460
Indian J Endocrinol Metab. 2012 Jan;16(1):56-66
pubmed: 22276253
Hypertension. 2015 Feb;65(2):291-8
pubmed: 25385758
J Health Popul Nutr. 2022 Mar 2;41(1):7
pubmed: 35236427
PLoS One. 2017 Oct 2;12(10):e0184264
pubmed: 28968435
BMC Public Health. 2019 Mar 25;19(1):341
pubmed: 30909905
Glob Heart. 2017 Jun;12(2):81-90
pubmed: 28302553
BMC Cardiovasc Disord. 2019 May 22;19(1):121
pubmed: 31117945
BMJ Glob Health. 2017 Aug 16;2(3):e000348
pubmed: 29082013
BMC Public Health. 2017 Feb 17;17(1):206
pubmed: 28212629
PLoS One. 2023 Jul 7;18(7):e0287794
pubmed: 37418394
Medicine (Baltimore). 2020 Nov 25;99(48):e23467
pubmed: 33235135
Glob Health Epidemiol Genom. 2016 Nov 29;1:e19
pubmed: 29868211
PLoS Med. 2019 Mar 1;16(3):e1002751
pubmed: 30822339
Ethn Dis. 2017 Apr 20;27(2):189-200
pubmed: 28439190